Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant ΔureC hly(+) Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine Tuberculosis

Benzer Materyaller

• Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant ΔureC hly(+) Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine Tuberculosis
  Yazar:: Tchilian, Elma Z., ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis
  Yazar:: Gengenbacher, Martin, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Recombinant BCG ΔureC hly+ Induces Superior Protection Over Parental BCG by Stimulating a Balanced Combination of Type 1 and Type 17 Cytokine Responses
  Yazar:: Desel, Christiane, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Central Memory CD4(+) T Cells Are Responsible for the Recombinant Bacillus Calmette-Guérin ΔureC::hly Vaccine's Superior Protection Against Tuberculosis
  Yazar:: Vogelzang, Alexis, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• The Tuberculosis Vaccine Candidate Bacillus Calmette-Guérin ΔureC::hly Coexpressing Human Interleukin-7 or -18 Enhances Antigen-Specific T Cell Responses in Mice
  Yazar:: Rao, Martin, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)